BNT162b2 Protection against the Omicron Variant in Children and Adolescents | NEJM - nejm.org

Correspondence from The New England Journal of Medicine — BNT162b2 Protection against the Omicron Variant in Children and Adolescents

To the Editor Price and colleagues (published online on March 30 at NEJM.org)1 describe the effectiveness of the BNT162b2 vaccine (PfizerBioNTech) against the B.1.1.529 (omicron) variant of SARS-Co… [+4284 chars]

full article...